Dongkook Pharmaceutical Co Ltd banner
D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 28 500 KRW 2.7% Market Closed
Market Cap: ₩1.3T

Wall Street
Price Targets

Price Targets Summary
Dongkook Pharmaceutical Co Ltd

Wall Street analysts forecast Dongkook Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 38 250 KRW with a low forecast of 30 300 KRW and a high forecast of 47 250 KRW.

Lowest
Price Target
30 300 KRW
6% Upside
Average
Price Target
38 250 KRW
34% Upside
Highest
Price Target
47 250 KRW
66% Upside
Dongkook Pharmaceutical Co Ltd Competitors:
Price Targets

Revenue
Forecast

13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
13% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 4 years is 13%.

Operating Income
Forecast

11% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 4 years is 18%.

Net Income
Forecast

12% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
12% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 3 years is 15%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dongkook Pharmaceutical Co Ltd's stock price target?
Price Target
38 250 KRW

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 38 250 KRW with a low forecast of 30 300 KRW and a high forecast of 47 250 KRW.

What is Dongkook Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 13%. The projected CAGR for the next 4 years is 13%.

What is Dongkook Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
18%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 11%. The projected CAGR for the next 4 years is 18%.

What is Dongkook Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
15%

For the last 11 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 12%. The projected CAGR for the next 3 years is 15%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett